Tech Company Financing Transactions
Cantex Pharmaceuticals Funding Round
Cantex Pharmaceuticals secured a $13.5 million funding round on 12/31/2014. Investors included Domain Associates and private investors.
Transaction Overview
Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$13,502,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1792 Bell Tower Ln.
Weston, FL 33326
USA
Weston, FL 33326
USA
Phone
Website
Email Address
Overview
Cantex Pharmaceuticals is a biotechnology company engaged in harnessing known therapies to develop novel and safer cancer treatments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Neil Flanzraich
Chief Executive Officer
Stephen Marcus
Chief Financial Officer
Juan Rodriguez
Browse more venture capital transactions:
Prev: 12/31/2014: nLight venture capital transaction
Next: 12/31/2014: Principia Biopharma venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs